Metraipolis › archive › dc_c98fc8954bec

mRNA-based immunotherapy platform targeting endometrial cancer — Europe PMC PMID:41345672

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41345672
DOI
10.1186/s12967-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-07T21:43:57.142Z
SHA-256 of the archived text
2f60753548295e540bc2a6357ca865b66df741bc4fe2a2b9f59905815583d946
Stable URL of this page
https://metraipolis.com/documento/dc_c98fc8954bec

How to cite

mRNA-based immunotherapy platform targeting endometrial cancer — Europe PMC PMID:41345672 — Europe PMC (en), https://europepmc.org/article/MED/41345672 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c98fc8954bec (Metraipolis archive dc_c98fc8954bec, sha256 2f60753548295e540bc2a6357ca865b66df741bc4fe2a2b9f59905815583d946)
BibTeX
@misc{dcc98fc8954bec,
  title = {mRNA-based immunotherapy platform targeting endometrial cancer — Europe PMC PMID:41345672},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41345672},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c98fc8954bec; sha256 2f60753548295e540bc2a6357ca865b66df741bc4fe2a2b9f59905815583d946},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41345672. Agents can read the archived copy with the MCP tool read_document.